Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0941820130230030248
Korean Journal of Clinical Pharmacy
2013 Volume.23 No. 3 p.248 ~ p.255
Investigation on the Current Labelling Trend of Tar Color Additives in Infant¡¯s Drugs Marketed in Korea
Kim Kwang-Joon

Bang Joon-Seok
Lee Won-Jae
Abstract
Objective: This paper was aimed to investigate the current labelling trend of tar color additives in infant¡¯s drugs used in Korea and other countries.

Method: The current labelling system of the tar color additives in infant¡¯s drugs was investigated using inserted papers for drug information of infant¡¯s drugs as well as three drug information internet sites popular in Korea including internet sites of foreign countries of USA, UK, Japan, and China for infant¡¯s drug information.

Results: Among 325 drugs registered as syrup form for infant¡¯s drugs (sources, http://www.health.kr), 4 drugs indicated tar color related information on the internet and only 2 drugs indicated tar color additives¡¯ name. And from the investigated results of 76 inserted papers for infant¡¯s drug information, among 31 drugs containing tar dyes, in only 19 drugs the tar color additives¡¯ names were notated. Among 6 drugs which do not contain tar dyes, only 1 drug was notated as ¡®Dye-Free¡¯.

Conclusion: For advanced labelling system in Korea, we proposed the below guidelines. [1] The name of tar color additives used in infant¡¯s drugs should be notated even in drug information on internet sites. [2] All drug ingredients used in infant¡¯s drugs need to be separately notated as active and inactive species on both internet sites and inserted papers. [3] ¡®Dye-Free¡¯ notation should be mandatory for infant¡¯s drugs which do not contain tar color additives in drug information on the internet sites as well as inserted papers.
KEYWORD
Tar color additives, Labelling trend, Infant¡¯s drugs
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)